Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation

NCT01627223 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Slow progress in recruiting study patients

Conditions

Chronic Hepatitis B

Interventions

DRUG: Lamivudine
DRUG: Entecavir

Sponsor

Taichung Veterans General Hospital

Collaborators

[object Object]